Trial Profile
Clinical Trials Insight: 700057340
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 02 Jul 2010
Price :
$35
*
At a glance
- Drugs B7-2 GM-CSF cancer gene therapy (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Radient Pharmaceuticals Corporation
- 24 Jun 2010 The initiation of this trial is pending return of a successful application to the Central Drugs Standard Control Organisation in India, according to a Radient Pharmaceuticals media release.
- 24 Jun 2010 New trial record